Literature DB >> 10521991

Evaluation of local excision for sessile-type lower rectal tumors.

Y Ishizaki1, Y Takeda, T Miyahara, T Tokutome.   

Abstract

BACKGROUND/AIMS: A study was undertaken to evaluate the surgical morbidity and risk of recurrence in patients undergoing local excision for rectal carcinoma.
METHODOLOGY: Twenty patients with well or moderately differentiated lesions less than 6 cm in diameter, which were difficult to remove endoscopically but had no clinically involved regional nodes, were eligible for local excision.
RESULTS: The transanal approach was simple and had few complications. After posterior parasacral excision, 3 patients developed rectocutaneous fistulas, and 1 of them died. None of the 12 patients with cancer extension limited to the lesser depth of the submucosa died of rectal cancer. Among 8 patients with cancer invasive into the greater depth of the submucosa or deeper, 5 underwent additional radical resection, and regional lymph node metastasis was revealed in 2.
CONCLUSIONS: Transanal excision is suitable for curative resection of lower rectal tumors when the cancer extends only to the lesser depth of the submucosa. The procedure should be defined as a total excisional biopsy until the results of histologic examination are obtained.

Entities:  

Mesh:

Year:  1999        PMID: 10521991

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Combining ultrasonic dissection and the Storz operation rectoscope.

Authors:  M M Lirici; M Di Paola; C Ponzano; C G S Hüscher
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

2.  Long-Term Outcomes and Lymph Node Metastasis in Patients Receiving Radical Surgery for Pathological T1 Lower Rectal Cancer.

Authors:  Daichi Kitaguchi; Takeshi Sasaki; Yuji Nishizawa; Yuichiro Tsukada; Masaaki Ito
Journal:  World J Surg       Date:  2019-02       Impact factor: 3.352

3.  Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.

Authors:  Takeshi Sasaki; Yoshinori Ito; Masayuki Ohue; Yukihide Kanemitsu; Takaya Kobatake; Masaaki Ito; Yoshihiro Moriya; Norio Saito
Journal:  Dis Colon Rectum       Date:  2017-09       Impact factor: 4.585

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.